Detalhe da pesquisa
1.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med
; 390(15): 1359-1371, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631003
2.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med
; 385(8): 683-694, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407342
3.
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
Br J Cancer
; 129(1): 38-45, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120671
4.
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.
Breast Cancer Res Treat
; 199(1): 35-46, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859649
5.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(9): 1133-1144, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055304
6.
Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data.
BMC Cancer
; 16: 703, 2016 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27581751
7.
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses.
Clin Cancer Res
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506710
8.
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
J Clin Oncol
; 42(3): 312-323, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931206
9.
Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre.
Cancer Med
; 12(5): 5255-5264, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207803
10.
The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I-Associated Peptides.
Cancer Immunol Res
; 11(6): 747-762, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961404
11.
Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study.
Bioanalysis
; 13(2): 101-113, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496610
12.
Treatment Strategies in Metastatic Renal Cancer: Dose Titration in Clear Cell Renal Cell Carcinoma.
Eur Urol
; 82(3): 293-294, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577645
13.
FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer.
J Immunother Cancer
; 5: 17, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28239470
14.
High-level production in Pichia pastoris of an anti-p185HER-2 single-chain antibody fragment using an alternative secretion expression vector.
Biotechnol Appl Biochem
; 39(Pt 1): 115-22, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12962542